Early Pars Plana Vitrectomy in Acute Endophthalmitis: The Manchester Series.

BACKGROUND AND OBJECTIVE Current literature lacks good-quality evidence regarding the outcomes of early pars plana vitrectomy (PPV) for acute exogenous endophthalmitis. The aim for this study was to analyze and discuss the outcomes of PPV for endophthalmitis in a UK tertiary hospital. PATIENTS AND METHODS This study was a retrospective case series. The clinical records of consecutive patients who had PPV for acute exogenous endophthalmitis were reviewed. Demographic data, etiology, timing of onset, timing of PPV, intraand postoperative complications, baseline and final best-corrected visual acuity (BCVA), therapeutic regimens, and microbiology details were collected. Primary efficacy and safety outcome measures were BCVA improvement of two or more logMAR lines and intra- or postoperative complications, respectively. RESULTS Forty-one patients with a median age of 76 (interquartile range, 64 to 82) years were studied. The most common etiology was intravitreal injection (41%), followed by phacoemulsification (34%). Median interval to PPV was 1.0 (interquartile range, 1.0 to 3.0) days. In a multivariate model controlling for age, baseline BCVA, microbiology positivity, and etiology (post-intravitreal injection), PPV after 24 hours was seven times more likely to achieve significant BCVA improvement (odds ratio, 7.47; 95% confidence interval, 1.12 to 49.66; P = .038). PPV within 24 hours of presentation was associated with more intraoperative complications. CONCLUSIONS Favorable outcomes may be achieved with current antibiotic regimens and PPV for endophthalmitis. The series suggests that an early surgical intervention may be associated with poorer functional outcomes. Tap and inject at presentation, followed by a semi-urgent PPV as required, seems to be a sensible approach. [Ophthalmic Surg Lasers Imaging Retina. 2022;53:96-102.].

[1]  R. Adelman,et al.  International Practice Patterns for the Management of Acute Postsurgical and Postintravitreal Injection Endophthalmitis: European Vitreo-Retinal Society Endophthalmitis Study Report 1. , 2019, Ophthalmology. Retina.

[2]  T. Williamson,et al.  Management of bacterial postoperative endophthalmitis and the role of vitrectomy. , 2018, Survey of ophthalmology.

[3]  A. Grzybowski,et al.  The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? , 2018, Acta ophthalmologica.

[4]  J. V. van Meurs,et al.  Another perspective on the treatment of postoperative endophthalmitis: Unclear evidence for the role of vitrectomy. , 2018, Acta ophthalmologica.

[5]  J. V. van Meurs,et al.  A prospective multicentre randomized placebo‐controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics , 2018, Acta ophthalmologica.

[6]  P. Allen,et al.  Predictors of visual outcome and the role of early vitrectomy in streptococcal endophthalmitis , 2018, Clinical & experimental ophthalmology.

[7]  David F Williams,et al.  Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes. , 2018, Ophthalmology.

[8]  H. Flynn,et al.  Endophthalmitis: Then and Now. , 2017, American journal of ophthalmology.

[9]  R. Agha,et al.  Preferred reporting of case series in surgery; the PROCESS guidelines. , 2016, International journal of surgery.

[10]  J. Roider,et al.  Vision loss under silicone oil tamponade , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  S. G. Schwartz,et al.  Update on the prevention and treatment of endophthalmitis , 2014, Expert review of ophthalmology.

[12]  C. Chiquet,et al.  Baseline factors predictive of visual prognosis in acute postoperative bacterial endophthalmitis in patients undergoing cataract surgery. , 2013, JAMA ophthalmology.

[13]  M. Durand Endophthalmitis , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  U. Stenevi,et al.  Six‐year incidence of endophthalmitis after cataract surgery: Swedish national study , 2013, Journal of cataract and refractive surgery.

[15]  M. Simunovic,et al.  Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes , 2012, British Journal of Ophthalmology.

[16]  C. Chiquet,et al.  23-gauge transconjunctival sutureless vitrectomy in treatment of post-operative endophthalmitis , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[17]  G. Yılmaz,et al.  The results of pars plana vitrectomy and silicone oil tamponade for endophthalmitis after intravitreal injections , 2012, International ophtalmology.

[18]  T. Theelen,et al.  Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. , 2010, American journal of ophthalmology.

[19]  H. Wong,et al.  Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis , 2008, Eye.

[20]  F. Kuhn,et al.  Complete and Early Vitrectomy for Endophthalmitis (CEVE) as Today’s Alternative to the Endophthalmitis Vitrectomy Study , 2007 .

[21]  F. Kuhn,et al.  Vitrectomy for endophthalmitis. , 2006, Ophthalmology.

[22]  J. Miller,et al.  The Endophthalmitis Vitrectomy Study. , 1996, Archives of ophthalmology.